The Global Infertility Testing and Treatment Market Calculated to Attain $32.94 Billion in Revenue by 2028

According to Triton’s report, the global infertility testing and treatment market, which obtained $13.43 billion in 2020, is probable to witness growth at 10.15% of CAGR by 2028.

A recent study by Triton Market Research titled ‘Global Infertility Testing and Treatment Market’ consist of the Global Analysis and Forecasts by End-user (Hospitals and Research Laboratories, Fertility and Surgical Centers, Cryobanks), Gender (Female [Female Infertility Treatment (IVF without ICSI, Surrogacy, IVF with ICSI, IUI, Others), Female Infertility Testing (Transvaginal Ultrasound, Hormonal Level Testing, Ovulation Testing, Laparoscopy, Hysterosalpingography, Ovarian Reserve Testing, Others)], Male [Male Infertility Treatment (Assisted Reproductive Technology & Varicocele Surgery, Medication), Male Infertility Testing (Sperm Penetration Assay, DNA Fragmentation, Sperm Agglutination, Computer-Assisted Semen Analysis (CASA), Microscopic Examination, Oxidative Stress Analysis, Others)]), and by Geography (North America, Middle East and Africa, Europe, Asia-Pacific, Latin America).

Request Free Sample of the Global Infertility and Treatment Market Report @ https://www.tritonmarketresearch.com/reports/infertility-testing-and-treatment-market#request-free-sample

Triton’s report predicts the global infertility testing and treatment market to advance based on revenue at a CAGR of 10.15% during the projected period of 2021-2028. It is anticipated to display revenue worth $32.94 billion by 2028.

The growing demand for infertility testing and treatments is mainly due to changes in lifestyles and inadequate nutrition.

Over the years, there has been a gradual change in lifestyles, leading to a rise in stress levels. This has further increased involuntary body responses, resulting in high blood pressure and hormonal imbalance. Hence, the increase in stress and lifestyle diseases, along with the growing trend in delayed pregnancies, augment the growth of the infertility testing and treatment market globally.

However, the high cost of infertility testing and treatments and social taboo surrounding infertility restrict the infertility testing and treatment market’s development.

The global infertility testing and treatment market is divided into end-user and gender. The end-user segment is categorized into hospitals and research laboratories, fertility and surgical centers, and cryobanks. Here, gender is segmented into female and male, with females further subdivided into female infertility treatment and female infertility testing. The female infertility treatment is sectioned into IVF without ICSI, surrogacy, IVF with ICSI, IUI, and others. Likewise, female infertility testing is branched into transvaginal ultrasound, hormonal level testing, ovulation testing, laparoscopy, hysterosalpingography, ovarian reserve testing, and
others.

Further, the male section is divided based on male infertility treatment and male infertility testing, with the former bifurcated into assisted reproductive technology & varicocele surgery and medication. Lastly, the latter is branched into sperm penetration assay, DNA fragmentation, sperm agglutination, computer-assisted semen analysis (CASA), microscopic examination, oxidative stress analysis, and others.

Globally, the Asia-Pacific is anticipated to witness the fastest growth in the infertility testing and treatment market. The development is mainly owing to the rise in medical tourism in major countries, such as China, Japan, India, and South Korea, among others. Moreover, in recent years, China and Japan have emerged as major countries offering advanced infertility services, including IVF treatments. Furthermore, the development in technology also acts as a key factor adding to the region’s growth. Hence, the growing medical tourism will drive the growth of the infertility testing and treatment market over the forecasted period across the region’s nations.

Cook Medical Inc, Vitrolife AB, Adorfem, Ferring Pharmaceuticals, Endo International Plc, EMD Group (Merck KGAA), Bangkok IVF Center, Cooper Surgical, Olympus Corporation, Fujifilm Irvine Scientific, Halotech DNA, Labotect GmbH, Progyny, Genea Ltd, and Create Fertility Centre are prominent market players in the infertility testing and treatment market.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/infertility-testing-and-treatment-market#purchase-option


Question & Answer: Infertility Testing and Treatment Market

Question 1: What factors augment the growth of the infertility testing and treatment market globally?

Answer: Over the years, there has been a gradual change in lifestyles, leading to a rise in stress levels. This has further increased involuntary body responses, resulting in high blood pressure and hormonal imbalance. Hence, the increase in stress and lifestyle diseases, along with the growing trend in delayed pregnancies, augment the growth of the infertility testing and treatment market globally.

Question 2: What factors restrict the infertility testing and treatment market development?

Answer: The high cost of infertility testing and treatments and social taboo surrounding infertility restrict the infertility testing and treatment market’s development.

Question 3: Which region is anticipated to witness the fastest growth in the infertility testing and
treatment market?

Answer: Globally, the Asia-Pacific is anticipated to witness the fastest growth in the infertility testing and treatment market. The development is mainly owing to the rise in medical tourism in major countries, such as China, Japan, India, and South Korea, among others. Moreover, in recent years, China and Japan have emerged as major countries offering advanced infertility services, including IVF treatments. Furthermore, the development in technology also acts as a key factor adding to the region’s growth. Hence, the growing medical tourism will drive the growth of the infertility testing and treatment market over the forecasted period across the region’s nations.

Question 4: Which are the prominent market players in the infertility testing and treatment market?

Answer: Cook Medical Inc, Vitrolife AB, Adorfem, Ferring Pharmaceuticals, Endo International Plc, EMD Group (Merck KGAA), Bangkok IVF Center, Cooper Surgical, Olympus Corporation, Fujifilm Irvine Scientific, Halotech DNA, Labotect GmbH, Progyny, Genea Ltd, and Create Fertility Centre are prominent market players in the infertility testing and treatment market.

Related Report:

Global Stem Cell Market

The global stem cell market is probable to display growth during 2021-2028 at a CAGR of 7.54%. It is likely to gain revenue worth $16782.2 million by 2028.

Stem cells are used for tissue regeneration and wound repair, among other treatments. In recent years, the tremendous growth in the geriatric population has enhanced the need for stem cell therapies across the globe.

Factors such as growing awareness pertaining to umbilical cord stem cells, coupled with the increasing demand for regenerative medicine, is boosting the studied market’s progression.

Additionally, the technological advancements and the risk of adverse immune reactions generate opportunities for the stem cell market over the forecast period.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.